ReviewCardiovascular drugs and therapy2021

Research Progress on the Involvement of ANGPTL4 and Loss-of-Function Variants in Lipid Metabolism and Coronary Heart Disease: Is the "Prime Time" of ANGPTL4-Targeted Therapy for Coronary Heart Disease Approaching?

Jingmin Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.